NanoViricides, Inc. (NYSE American: NNVC) announced its broad-spectrum antiviral NV-387 as a potential solution for combating H5N1 bird flu, stating ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...